BOSTON, May 14, 2019 /PRNewswire/ — The Digital Medicine Society (DiMe), a Massachusetts nonprofit corporation with 501(c)(3) application pending, has launched.
DiMe is a new professional society serving individuals at the intersection of the global healthcare and technology communities. It supports the development of digital medicine through interdisciplinary collaboration, research, teaching, and the promotion of best practices.
“Cross-discipline cooperative networks are needed to unlock the full potential of digital medicine to improve human health,” said DiMe Executive Director Jennifer Goldsack. “DiMe provides the only professional home for individuals across digital medicine—from regulators to white-hat hackers, ethicists to engineers, and clinicians to citizen scientists. We look forward to welcoming a diverse membership to DiMe and, together, driving scientific progress and broad acceptance of digital medicine to enhance public health.”
Experts from across digital medicine disciplines sit on DiMe’s Scientific Leadership and Strategic Advisory Boards:
DiMe members will have a variety of ways to influence the research agenda and participate in inter-disciplinary workgroups, such as defining requirements for verification and validation processes and developing consensus recommendations on ethics in digital medicine. In addition, members have access to live webinars and workshops, collaborative and communications platforms, careers services, and discounts with DiMe partner organizations.
The Digital Medicine Society
The Digital Medicine Society (DiMe) is a professional society serving the digital medicine community. Together, we drive scientific progress and broad acceptance of digital medicine to enhance public health.
Media Contact
Michelle Sechser
michelle@dimesociety.org
View original content to download multimedia:http://www.prnewswire.com/news-releases/digital-medicine-society-now-accepting-members-300848402.html
SOURCE Digital Medicine Society (DiMe)
SAN DIEGO, CA / ACCESS Newswire / December 22, 2025 / CV Sciences, Inc. (OTCQB:CVSI)…
The New Year Introduces Continuum's Entry-Level Tier, Starting at $25,000 Per YearNEW YORK, Dec. 22,…
BOSTON, Dec. 22, 2025 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA) today announced its partnership with…
CHICAGO, Dec. 22, 2025 /PRNewswire/ -- TrustCommerce®, a Sphere company and leading provider of end-to-end…
MIAMI, Dec. 22, 2025 /PRNewswire/ -- BioFlorida, Inc. ("BioFlorida"), Florida's preeminent life sciences association, is…
Andreessen Horowitz leads the funding round which will accelerate the company's leadingtelehealth marketplaceAUSTIN, Texas, Dec.…